News
For people who constantly think about what they are going to eat meal to meal, their food noise goes down significantly’ ...
The first study to put two GLP-1 weight loss drugs head-to-head found Zepbound helped people lose more weight than Wegovy.
In this 2025 availability update, Remote Pharmacy highlights the expanded access to non-branded GLP-1-based weight management ...
Lizzo has been on what she called an intentional weight release journey, and she's sharing more secrets behind her body transformation.
Improving access and affordability could be transformative for public health, given that about 88% of Americans are ...
VK2735 shows strong early weight loss data, positioning Viking Therapeutics as a potential third major player in the booming GLP-1 obesity drug market. Learn more on VKTX stock here.
France 24 on MSN16h
The big business behind weight-loss drugs: Global market to hit $150 billion by 2035They burst onto the scene four years ago and are taking over the pharmaceutical world. New GLP-1-based drugs like Ozempic, Wegovy or Zepbound are said to be a weight-loss game changer and could drive ...
Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.
Once everyone’s had enough of injections, side effects, and the vast expense of GLP-1 drugs, it could be natural alternatives ...
GLP-1RA use necessitated shifting priorities in nutrition and lifestyle modification among patients with obesity, according ...
Instant ramen maker Nissin Foods is leveraging the buzz around GLP-1s to launch in the US a trio of decadent tasting frozen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results